Increased Adoption of dPCR Technology Accelerating Growth in the Global qPCR and dPCR Market

Reportstack has announced a new market research report on the Global qPCR and dPCR Market 2015-2019, which is expected to post a CAGR of 9.67 percent during the period 2014-2019.

qPCR technology allows for the amplification and quantification of a target DNA molecule in real time. It focuses primarily on the exponential phase, calculating two values, to provide very accurate data for quantification. dPCR technology allows for the statistical analysis of PCR products by converting exponential, analog signals obtained from conventional PCR technology to linear, digital signals.

“The advanced dPCR technology helps researchers to complete the drug development process in a short period of time with a high level of precision and efficiency,”.

Key Market Drivers

Advances in Technology
Increased Focus on Clinical Research
Demand for High-throughput Technology
Growing Demand for Accurate Diagnostic Technology

Key Market Trends

Adoption of dPCR Technology
Increase in M&A
Increased Outsourcing Activities
Preference for Personalized Medicines

Key Market Vendors

Abbott Laboratories
Agilent Technologies Inc.
Bio-Rad Laboratories Inc.
F. Hoffmann-La Roche Ltd.
Qiagen N.V.
Thermo Fisher Scientific Inc.

To define the market circumstances in the next 3-4 years, the analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.

To view the table of contents and know more details please visit Global qPCR and dPCR Market 2015-2019.